BioSpace News Archive

Biotech Bay

Outset Medical to Present at Upcoming September Investor Conferences

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming virtual investor conferences.

August 26, 2021
·
1 min read
Pharm Country

Cellectis Announces Participation in Five Investor Conferences

Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), today announced that management plans to participate in five virtual investor conferences.

August 26, 2021
·
4 min read
BioCapital

Incyte and MorphoSys Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Incyte (Nasdaq:INCY) and MorphoSys AG (FSE:MOR; NASDAQ:MOR) today announced that the European Commission (EC) has granted conditional marketing authorization for Minjuvi® (tafasitamab) in combination with lenalidomide.

August 26, 2021
·
13 min read
BioMidwest

Invacare Corporation to Participate at September 2021 Conferences

Invacare Corporation a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for September 2021:

August 26, 2021
·
1 min read
Pharm Country

BD to Present at Two Upcoming Virtual Healthcare Investor Conferences in September

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor conferences:

August 26, 2021
·
1 min read
Business

CytoDyn Appoints Seenu Srinivasan, Ph.D. as Executive Director of CMC Regulatory Affairs

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.

August 26, 2021
·
12 min read
Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody

Junshi Biosciences (HKEX: 1877; SSE: 688180), announced today that the National Medical Products Administration (NMPA) of China has accepted an investigational new drug application for UBP1213sc, its subcutaneous injection of recombinant humanized anti-BLyS monoclonal antibody.

August 26, 2021
·
3 min read
BioMidwest

COVID-19 in children with cancer: Severe disease and disrupted treatment

Research from a large international effort shows that 20% of children with cancer who are infected with SARS-CoV-2 develop severe infections.

August 26, 2021
·
7 min read
Business

Patterson Companies Fiscal 2022 First-Quarter Conference Call Scheduled for Thursday, September 2, 2021

Patterson Companies announced that it will hold its fiscal 2022 first-quarter conference call on Thursday, September 2, 2021 at 7:30 a.m. CT.

August 26, 2021
·
1 min read
Business

Virpax Announces MMS019 Manufacturing and Supply Agreement

Virpax ® Pharmaceuticals, Inc. today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe.

August 26, 2021
·
5 min read